fusion pharmaceuticals - Robuta Search

Sponsored by eBay

https://www.prnewswire.com/news-releases/fusion-pharmaceuticals-appoints-dmitri-bobilev-md-as-chief-medical-officer-301670776.html Fusion Pharmaceuticals Appoints Dmitri Bobilev, M.D. as Chief Medical Officer /PRNewswire/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as... fusion pharmaceuticals d as appoints dmitri https://www.newswire.ca/news-releases/fusion-pharmaceuticals-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4--844739338.html Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) /CNW/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as... fusion pharmaceuticals https://www.biospace.com/fusion-pharmaceuticals-to-be-acquired-by-astrazeneca-accelerating-development-of-next-generation-radioconjugates-to-treat-cancer Fusion Pharmaceuticals to be Acquired by AstraZeneca, Accelerating Development of Next-Generation... Sep 20, 2024 - Fusion Pharmaceuticals Inc., a clinical-stage oncology company focused on developing next-generation radioconjugates as precision medicines, announced the... to be acquired fusion pharmaceuticals https://www.biospace.com/fusion-pharmaceuticals-reports-first-quarter-2024-financial-results-and-announces-clinical-program-updates Fusion Pharmaceuticals Reports First Quarter 2024 Financial Results and Announces Clinical Program... Sep 20, 2024 - Fusion Pharmaceuticals Inc. reported financial results for the first quarter ended March 31, 2024, and provided an update on clinical and corporate... fusion pharmaceuticals first quarter https://www.biospace.com/fusion-pharmaceuticals-to-present-at-the-jefferies-virtual-london-healthcare-conference Fusion Pharmaceuticals to Present at the Jefferies Virtual London Healthcare Conference - BioSpace Nov 13, 2020 - Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision... fusion pharmaceuticals at the https://www.biospace.com/fusion-pharmaceuticals-announces-pricing-of-initial-public-offering-june-26-2020 Fusion Pharmaceuticals Announces Pricing of Initial Public Offering - June 26, 2020 - BioSpace Jun 26, 2020 - Fusion Pharmaceuticals Inc., a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, announced the... initial public offering fusion pharmaceuticals https://www.prnewswire.com/news-releases/fusion-pharmaceuticals-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-301463053.html Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) /PRNewswire/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as... fusion pharmaceuticals